lilly-logo-2--1
Photo: Courtesy of Eli Lilly
24 March 2016Big Pharma

UK Supreme Court to hear Alimta patent dispute

The UK Supreme Court has said it will hear a patent dispute between Eli Lilly and Allergan centring on cancer drug Alimta (pemetrexed disodium).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
15 February 2016   Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta.
Big Pharma
8 March 2016   In February the English High Court ruled that Actavis had not indirectly infringed a patent owned by Eli Lilly directed to cancer drug Alimta. David Read of Bartle Read reports.

More on this story

Big Pharma
15 February 2016   Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta.
Big Pharma
8 March 2016   In February the English High Court ruled that Actavis had not indirectly infringed a patent owned by Eli Lilly directed to cancer drug Alimta. David Read of Bartle Read reports.

More on this story

Big Pharma
15 February 2016   Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta.
Big Pharma
8 March 2016   In February the English High Court ruled that Actavis had not indirectly infringed a patent owned by Eli Lilly directed to cancer drug Alimta. David Read of Bartle Read reports.